Cannabis terpenes produced pain-relieving effects that were roughly equal to those of morphine.
Region: AZ
The study’s authors concluded, “Current evidence suggests an association between nicotine-product use and subsequent recreational cannabis use among adolescents.”
The new policy takes effect in January.
Investigators concluded, “There is an urgent need to implement well-designed studies to evaluate the effectiveness and safety of medical marijuana for treating adults with migraines.”
Justices determined, “Because the use of marijuana under AMMA ‘must be considered the equivalent of the use of any other medication,’ … the exposure of [the plaintiff’s] infant to marijuana … did not constitute neglect.”
Adult use sales first began in mid-January. By November, monthly sales of adult-use products exceeded those of medical cannabis.
Researchers concluded, “In the absence of clear evidence-based treatments for these symptoms, use of CBD may be useful in improving symptoms among these patients.”
Investigators concluded, “This study is thus the first to show that terpenes and cannabinoids can produce an additive effect when combined.”